Detailed answers about LUMAMI PHARMACEUTICALS SERVICES LIMITED, including incorporation, status, business activity, and accounts information.
When was LUMAMI PHARMACEUTICALS SERVICES LIMITED founded?
LUMAMI PHARMACEUTICALS SERVICES LIMITED was officially incorporated on 19 May 2026 and is registered under company number 17230562. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is LUMAMI PHARMACEUTICALS SERVICES LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of LUMAMI PHARMACEUTICALS SERVICES LIMITED?
LUMAMI PHARMACEUTICALS SERVICES LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does LUMAMI PHARMACEUTICALS SERVICES LIMITED do?
LUMAMI PHARMACEUTICALS SERVICES LIMITED operates in the following sectors: 86101 - Hospital activities, 86102 - Medical nursing home activities, 86210 - General medical practice activities, 86900 - Other human health activities. These SIC codes provide insight into the company's business activities and industry focus.
What is LUMAMI PHARMACEUTICALS SERVICES LIMITED's registered address?
The registered office address of LUMAMI PHARMACEUTICALS SERVICES LIMITED is 71-75 Shelton Street, Covent Garden, London, United Kingdom, WC2H 9JQ. This is the official address filed with Companies House for legal and statutory correspondence.
Is LUMAMI PHARMACEUTICALS SERVICES LIMITED financially stable?
Financial accounts for LUMAMI PHARMACEUTICALS SERVICES LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.